First Hedgehog Pathway Inhibitor Approved in AML Patients

Clinicians now have a new treatment to offer elderly patients with newly diagnosed acute myeloid leukemia who have comorbidities that preclude the use of intensive chemotherapy. (Source: CancerNetwork)

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2ErMORn
via IFTTT